Previous Article
Newly approved drug is a major advancement for patients with ulcerative colitis
Newly approved drug is a major advancement for patients with ulcerative colitis

Michael Chiorean, M.D., co-director of the IBD Center at Swedish, was an investigator in the study that hel...

Next Article
TeamBirth maternity program launches at Providence Swedish
TeamBirth maternity program launches at Providence Swedish

The initiative, a joint venture with the Washington State Hospital Association and others, seeks to ensure ...